Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   Multi-scale signaling and tumor evolution in high-grade gliomas
  2. Liu, Jingxian; Cao, Song; Imbach, Kathleen J; Gritsenko, Marina A; Lih, Tung-Shing M; Kyle, Jennifer E; Yaron-Barir, Tomer M; Binder, Zev A; Li, Yize; Strunilin, Ilya; Wang, Yi-Ting; Tsai, Chia-Feng; Ma, Weiping; Chen, Lijun; Clark, Natalie M; Shinkle, Andrew; Naser Al Deen, Nataly; Caravan, Wagma; Houston, Andrew; Simin, Faria Anjum; Wyczalkowski, Matthew A; Wang, Liang-Bo; Storrs, Erik; Chen, Siqi; Illindala, Ritvik; Li, Yuping D; Jayasinghe, Reyka G; Rykunov, Dmitry; Cottingham, Sandra L; Chu, Rosalie K; Weitz, Karl K; Moore, Ronald J; Sagendorf, Tyler; Petyuk, Vladislav A; Nestor, Michael; Bramer, Lisa M; Stratton, Kelly G; Schepmoes, Athena A; Couvillion, Sneha P; Eder, Josie; Kim, Young-Mo; Gao, Yuqian; Fillmore, Thomas L; Zhao, Rui; Monroe, Matthew E; Southard-Smith, Austin N; Li, Yang E; Jui-Hsien Lu, Rita; Johnson, Jared L; Wiznerowicz, Maciej; Hostetter, Galen; Newton, Chelsea J; Ketchum, Karen A; Thangudu, Ratna R; Barnholtz-Sloan, Jill S; Wang, Pei; Fenyö, David; An, Eunkyung; Thiagarajan,Mathangi; Robles, Ana I; Mani, D R; Smith, Richard D; Porta-Pardo, Eduard; Cantley, Lewis C; Iavarone, Antonio; Chen, Feng; Mesri, Mehdi; Nasrallah, MacLean P; Zhang, Hui; Resnick, Adam C; Chheda, Milan G; Rodland, Karin D; Liu, Tao; Ding, Li
  3. Cancer Cell. 2024, Jul 08; 42(7): 1217-1238.e19.
  1. 2.   Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques
  2. Rowe, Lindsay S.; Harmon,Stephanie; Horn, Adam; Shankavaram, Uma; Roy, Soumyajit; Ning, Holly; Lindenberg, Liza; Mena, Esther; Citrin, Deborah E.; Choyke, Peter; Turkbey, Baris
  3. Radiation Oncology. 2021, Feb 10; 16(1):
  1. 3.   Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model
  2. Harrington, Brittney S; Ozaki, Michelle K; Caminear, Michael W; Hernandez, Lidia F; Jordan, Elizabeth; Kalinowski, Nicholas J; Goldlust, Ian S; Guha, Rajarshi; Ferrer, Marc; Thomas,Craig; Shetty,Jyoti; Tran,Bao; Wong,Nathan; House, Carrie D; Annunziata, Christina M
  3. Cancers. 2020, Jun 21; 12(6): pii: E1645.
  1. 4.   18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy
  2. Mena, Esther; Lindenberg, Maria Liza; Turkbey, Ismael Baris; Shih, Joanna H; Harmon,Stephanie; Lim, Ilhan; Lin, Frank I; Adler,Stephen; Eclarinal, Philip; McKinney, Yolanda; Citrin, Deborah; Dahut, William; Wood, Bradford; Krishnasamy, Venkatesh; Chang, Richard; Levy, Elliot; Merino, Maria; Pinto, Peter; Eary, Janet F; Choyke, Peter L
  3. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2020, JUN 1; 61(6): 881-889.
  1. 5.   Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness
  2. Boufraqech, Myriem; Patel, Dhaval; Nilubol, Naris; Powers, Astin; King, Timothy; Shell, Jasmine; Lack,Justin; Zhang, Lisa; Gara, Sudheer Kumar; Gunda, Viswanath; Klubo-Gwiezdzinska, Joanna; Kumar, Suresh; Fagin, James; Knauf, Jeffrey; Parangi, Sareh; Venzon, David; Quezado, Martha; Kebebew, Electron
  3. THYROID. 2019, Jan 1; 29(1): 79-92.
  1. 6.   Clinical impact of PSMA-based (18)F-DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy
  2. Mena, Esther; Lindenberg, Maria L; Shih, Joanna H; Adler, Stephen; Harmon, Stephanie; Bergvall, Ethan; Citrin, Deborah; Dahut, William; Ton, Anita T; McKinney, Yolanda; Weaver, Juanita; Eclarinal, Philip; Forest, Alicia; Afari, George; Bhattacharyya, Sibaprasad; Mease, Ronnie C; Merino, Maria J; Pinto, Peter; Wood, Bradford J; Jacobs, Paula; Pomper, Martin G; Choyke, Peter L; Turkbey, Baris
  3. European Journal of Nuclear Medicine and Molecular Imaging. 2018, Jan; 45(1): 4-11.
  1. 7.   Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin
  2. Day, C. P.; Carter, J.; Bonomi, C.; Hollingshead, M.; Merlino, G.
  3. International Journal of Cancer. 2012, Jan; 130(1): 190-199.
  1. 8.   MRI of localized prostate cancer: coming of age in the PSA era
  2. Turkbey, B.; Bernardo, M.; Merino, M. J.; Wood, B. J.; Pinto, P. A.; Choyke, P. L.
  3. Diagnostic and Interventional Radiology. 2012, Jan-Feb; 18(1): 34-45.
  1. 9.   The Untapped Potential of Genetically Engineered Mouse Models in Chemoprevention Research: Opportunities and Challenges
  2. Abate-Shen, C.; Brown, P. H.; Colburn, N. H.; Gerner, E. W.; Green, J. E.; Lipkin, M.; Nelson, W. G.; Threadgill, D.
  3. Cancer Prevention Research. 2008 1(3): 161-166.
  1. 10.   An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments
  2. Nam, J. S.; Terabe, M.; Mamura, M.; Kang, N. J.; Chae, H.; Stuelten, C.; Kohn, E.; Tang, B.; Sabzevari, H.; Anver, M. R.; Lawrence, S.; Danielpour, D.; Lonning, S.; Berzofsky, J. A.; Wakefield, L. M.
  3. Cancer Research. 2008 68(10): 3835-3843.
  1. 11.   A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer
  2. Burger, A. M.; Gao, Y. G.; Amemiya, Y.; Kahn, H. J.; Kitching, R.; Yang, Y. L.; Sun, P.; Narod, S. A.; Hanna, W. M.; Seth, A. K.
  3. Cancer Research. 2005, NOV 15; 65(22): 10401-10412.
  1. 12.   Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
  2. Takeda, K.; Yamaguchi, N.; Akiba, H.; Kojima, Y.; Hayakawa, Y.; Tanner, J. E.; Sayers, T. J.; Seki, N.; Okumura, K.; Yagita, H.; Smyth, M. J.
  3. Journal of Experimental Medicine. 2004 199(4): 437-448.
  1. 13.   Comparative molecular genetic profiles of anaplastic astrocytomas glioblastomas multiforme and their subsequent recurrences
  2. Saxena, A.; Shriml, L. M.; Dean, M.; Ali, I. U.
  3. Oncogene. 1999 18(6): 1385-1390.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel